Pharmacokinetics and Pharmacogenetics of Apixaban

Apixaban is oral anticoagulant, it is widely used in prevention of stroke in non-valvular atrial fibrillation and treatment of deep vein thrombosis and pulmonary embolism. Its main mechanism of action is through reversible inhibition of factor Xa. It specifically binds and inhibits both free and bou...

詳細記述

書誌詳細

出版年:	Рациональная фармакотерапия в кардиологии
主要な著者:	A. V. Savinova, M. M. Petrova, N. A. Shnayder, E. N. Bochanova, R. F. Nasyrova
フォーマット:	論文
言語:	英語
出版事項:	Столичная издательская компания 2020-11-01
主題:	apixaban pharmacokinetics pharmacogenetics effectiveness safety cyp3a5 sult1a1 abcb1 abcg2
オンライン･アクセス:	https://www.rpcardio.online/jour/article/view/2316